NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90α/EZH2/CXCL9 axis in colon cancer
Author:
Jiaqi Liu,Yixi Su,Chi Zhang,Haiyan Dong,Runfeng Yu,Xin Yang,Yu Tian,Yanchun Feng,Jingdan Zhang,Mengchen Shi,Chen Wang,Weiqian Li,Jun Liu,Lingyuan He,Xiangling Yang,Huanliang Liu
Publication:
International Immunopharmacology
© 2025 The Authors. Published by Elsevier B.V.